KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Inventory (2017 - 2026)

Guardant Health's Inventory history spans 9 years, with the latest figure at $85.9 million for Q4 2025.

  • On a quarterly basis, Inventory rose 20.81% to $85.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $85.9 million, a 20.81% increase, with the full-year FY2025 number at $85.9 million, up 20.81% from a year prior.
  • Inventory hit $85.9 million in Q4 2025 for Guardant Health, down from $90.5 million in the prior quarter.
  • Over the last five years, Inventory for GH hit a ceiling of $90.5 million in Q3 2025 and a floor of $24.7 million in Q3 2021.
  • Historically, Inventory has averaged $58.9 million across 5 years, with a median of $62.5 million in 2023.
  • Biggest five-year swings in Inventory: fell 10.79% in 2021 and later soared 154.85% in 2022.
  • Tracing GH's Inventory over 5 years: stood at $30.7 million in 2021, then skyrocketed by 68.21% to $51.6 million in 2022, then increased by 20.06% to $61.9 million in 2023, then grew by 14.75% to $71.1 million in 2024, then grew by 20.81% to $85.9 million in 2025.
  • Business Quant data shows Inventory for GH at $85.9 million in Q4 2025, $90.5 million in Q3 2025, and $84.1 million in Q2 2025.